CCDC68 is upregulated in NSCLC, and downregulating CCDC68 expression decreases cell proliferation and increases apoptosis, suggesting that CCDC68 is a candidate biomarker for the detection of malignant transformation in lung cancer (16). Here, CCDC68 is linked to lung carcinoma.